Winter Newsletter – The Authority in RWE

Winter Newsletter – The Authority in RWE

  STATinMED at ASH 2022 64th Annual ASH Meeting & Exposition: Dec 10-13, 2022, New Orleans, LA Presentations Oral Presentation: National view of prevalent and newly-diagnosed patients with multiple myeloma in 2021: A retrospective analysis of national...
Meet Maxine Fisher, PhD Part 1

Meet Maxine Fisher, PhD Part 1

Our Vice President, Real-World Evidence (RWE) shares her perspective about HEOR, RWD, evidence generation, and more. (First in a 2-part series) What is the current landscape for pharmaceutical and biotechnology products? It is an exciting time. I’ve spent 30 years in...
Winter Newsletter – The Authority in RWE

Quarterly Newsletter – RWD Insights & Custom Registry

Access robust business intelligence from a reliable team of analysts who understand your goals   Get timely real-world data insights to make business decisions quickly Contact us about RWD Insights Direct STATinMED RWD Custom Registry Actionable, research-ready data...
Top 3 Provisions & Top 5 Recommendations: The Inflation Reduction Act & RWD Insights

Meet Maxine Fisher, PhD – Part 2

More from our VP of RWE, Maxine Fisher, PhD What is the team’s approach with RWD to generate evidence and demonstrate value? One thing that is very motivating about working at STATinMED is our collaborative and consultative approach to generating evidence. RWD...
Robust, Actionable Research-Ready Claims Data

Robust, Actionable Research-Ready Claims Data

              Introducing… Timely resource based on index dates with ability to track time-varying events Patient-centric insights about treatment journey De-identified, tokenized, HIPAA-compliant   Views You Can Use       Collect the variables to...